vs

Side-by-side financial comparison of FIRST COMMUNITY BANKSHARES INC (FCBC) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.

4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $43.8M, roughly 1.9× FIRST COMMUNITY BANKSHARES INC). FIRST COMMUNITY BANKSHARES INC runs the higher net margin — 28.5% vs 22.8%, a 5.7% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 5.1%). FIRST COMMUNITY BANKSHARES INC produced more free cash flow last quarter ($60.0M vs $28.5M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 3.5%).

First Community Bankshares, Inc. is a $2.43 billion bank holding company and the parent company of First Community Bank of Bluefield, Virginia, in the United States. As of 2012 First Community Bank had 45 locations in Virginia, West Virginia, and North Carolina, and two locations operating as Peoples Community Bank in Tennessee. As of April 21, 2023, First Community had $3.6 billion in assets.

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

FCBC vs FDMT — Head-to-Head

Bigger by revenue
FDMT
FDMT
1.9× larger
FDMT
$85.1M
$43.8M
FCBC
Growing faster (revenue YoY)
FDMT
FDMT
+8508894.9% gap
FDMT
8508900.0%
5.1%
FCBC
Higher net margin
FCBC
FCBC
5.7% more per $
FCBC
28.5%
22.8%
FDMT
More free cash flow
FCBC
FCBC
$31.5M more FCF
FCBC
$60.0M
$28.5M
FDMT
Faster 2-yr revenue CAGR
FDMT
FDMT
Annualised
FDMT
5412.6%
3.5%
FCBC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FCBC
FCBC
FDMT
FDMT
Revenue
$43.8M
$85.1M
Net Profit
$12.5M
$19.4M
Gross Margin
Operating Margin
36.8%
17.3%
Net Margin
28.5%
22.8%
Revenue YoY
5.1%
8508900.0%
Net Profit YoY
-4.4%
139.1%
EPS (diluted)
$0.67
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FCBC
FCBC
FDMT
FDMT
Q4 25
$43.8M
$85.1M
Q3 25
$42.2M
$90.0K
Q2 25
$41.0M
$15.0K
Q1 25
$40.5M
$14.0K
Q4 24
$41.7M
$1.0K
Q3 24
$42.0M
$3.0K
Q2 24
$41.3M
$5.0K
Q1 24
$40.9M
$28.0K
Net Profit
FCBC
FCBC
FDMT
FDMT
Q4 25
$12.5M
$19.4M
Q3 25
$12.3M
$-56.9M
Q2 25
$12.2M
$-54.7M
Q1 25
$11.8M
$-48.0M
Q4 24
$13.0M
Q3 24
$13.0M
$-43.8M
Q2 24
$12.7M
$-35.0M
Q1 24
$12.8M
$-32.4M
Operating Margin
FCBC
FCBC
FDMT
FDMT
Q4 25
36.8%
17.3%
Q3 25
37.7%
-67983.3%
Q2 25
38.6%
-396373.3%
Q1 25
37.7%
-383007.1%
Q4 24
39.6%
Q3 24
39.3%
-1704400.0%
Q2 24
39.3%
-849120.0%
Q1 24
40.3%
-136200.0%
Net Margin
FCBC
FCBC
FDMT
FDMT
Q4 25
28.5%
22.8%
Q3 25
29.1%
-63195.6%
Q2 25
29.9%
-364386.7%
Q1 25
29.2%
-342657.1%
Q4 24
31.3%
Q3 24
31.0%
-1461433.3%
Q2 24
30.8%
-699060.0%
Q1 24
31.4%
-115717.9%
EPS (diluted)
FCBC
FCBC
FDMT
FDMT
Q4 25
$0.67
$0.43
Q3 25
$0.67
$-1.01
Q2 25
$0.67
$-0.98
Q1 25
$0.64
$-0.86
Q4 24
$0.67
Q3 24
$0.71
$-0.79
Q2 24
$0.71
$-0.63
Q1 24
$0.71
$-0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FCBC
FCBC
FDMT
FDMT
Cash + ST InvestmentsLiquidity on hand
$402.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$500.5M
$505.7M
Total Assets
$3.3B
$566.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FCBC
FCBC
FDMT
FDMT
Q4 25
$402.7M
Q3 25
$305.1M
Q2 25
$293.2M
Q1 25
$321.4M
Q4 24
$424.9M
Q3 24
$501.9M
Q2 24
$541.9M
Q1 24
$525.9M
Total Debt
FCBC
FCBC
FDMT
FDMT
Q4 25
Q3 25
$0
Q2 25
$0
Q1 25
$0
Q4 24
$0
Q3 24
$0
Q2 24
$0
Q1 24
$0
Stockholders' Equity
FCBC
FCBC
FDMT
FDMT
Q4 25
$500.5M
$505.7M
Q3 25
$510.7M
$369.0M
Q2 25
$502.8M
$420.9M
Q1 25
$496.4M
$469.7M
Q4 24
$526.4M
$510.6M
Q3 24
$520.7M
$552.9M
Q2 24
$508.9M
$588.3M
Q1 24
$506.9M
$600.6M
Total Assets
FCBC
FCBC
FDMT
FDMT
Q4 25
$3.3B
$566.7M
Q3 25
$3.2B
$424.0M
Q2 25
$3.2B
$473.6M
Q1 25
$3.2B
$515.7M
Q4 24
$3.3B
$560.4M
Q3 24
$3.2B
$604.0M
Q2 24
$3.2B
$620.1M
Q1 24
$3.2B
$629.9M
Debt / Equity
FCBC
FCBC
FDMT
FDMT
Q4 25
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FCBC
FCBC
FDMT
FDMT
Operating Cash FlowLast quarter
$62.7M
$28.6M
Free Cash FlowOCF − Capex
$60.0M
$28.5M
FCF MarginFCF / Revenue
137.0%
33.5%
Capex IntensityCapex / Revenue
6.3%
0.1%
Cash ConversionOCF / Net Profit
5.03×
1.47×
TTM Free Cash FlowTrailing 4 quarters
$100.6M
$-109.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FCBC
FCBC
FDMT
FDMT
Q4 25
$62.7M
$28.6M
Q3 25
$18.9M
$-46.5M
Q2 25
$10.2M
$-43.4M
Q1 25
$13.2M
$-47.8M
Q4 24
$57.7M
$-134.6M
Q3 24
$11.4M
$-29.4M
Q2 24
$14.5M
$-30.2M
Q1 24
$16.9M
$-29.1M
Free Cash Flow
FCBC
FCBC
FDMT
FDMT
Q4 25
$60.0M
$28.5M
Q3 25
$18.5M
$-46.6M
Q2 25
$10.0M
$-43.4M
Q1 25
$12.1M
$-48.4M
Q4 24
$54.9M
$-138.4M
Q3 24
$10.9M
$-31.2M
Q2 24
$14.1M
$-30.6M
Q1 24
$15.2M
$-29.8M
FCF Margin
FCBC
FCBC
FDMT
FDMT
Q4 25
137.0%
33.5%
Q3 25
43.9%
-51765.6%
Q2 25
24.3%
-289620.0%
Q1 25
29.8%
-345635.7%
Q4 24
131.8%
-13837100.0%
Q3 24
26.0%
-1038966.7%
Q2 24
34.1%
-611840.0%
Q1 24
37.1%
-106421.4%
Capex Intensity
FCBC
FCBC
FDMT
FDMT
Q4 25
6.3%
0.1%
Q3 25
1.0%
101.1%
Q2 25
0.6%
440.0%
Q1 25
2.8%
4507.1%
Q4 24
6.7%
378600.0%
Q3 24
1.2%
59266.7%
Q2 24
0.9%
6980.0%
Q1 24
4.4%
2535.7%
Cash Conversion
FCBC
FCBC
FDMT
FDMT
Q4 25
5.03×
1.47×
Q3 25
1.54×
Q2 25
0.83×
Q1 25
1.12×
Q4 24
4.43×
Q3 24
0.88×
Q2 24
1.14×
Q1 24
1.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons